Jian Luo1, Ivan Pavlov2, Elsa Tavernier3, John G Laffey4, Claude Guerin5, David Vines6, Yonatan Perez7, Oriol Roca8, Aileen Kharat9, Bairbre McNicholas4, Miguel Ibarra-Estrada10, Wei Tan11, Stephan Ehrmann12, Jie Li13. 1. Respiratory Medicine Unit and Oxford National Institute for Health and Care Research Biomedical Research Centre, Nuffield Department of Medicine, Experimental Medicine, University of Oxford, Oxford, UK. 2. Department of Emergency Medicine, Hôpital de Verdun, Montréal, QC, Canada. 3. Clinical Investigation Centre, INSERM 1415, CHRU Tours, Tours, France and Methods in Patients-Centred Outcomes and Health Research, INSERM UMR 1246, Nantes, France. 4. Department of Anesthesia and Intensive Care Medicine, Galway University Hospitals and School of Medicine, National University of Ireland, Galway, Ireland. 5. Médecine Intensive Réanimation, Hôpital Édouard Herriot, Lyon, France, and Université de Lyon, France, and Institut Mondor de Recherches Biomédicales, Créteil, France. 6. Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, IL 60612, USA. 7. CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, Tours, France. 8. Servei de Medicina Intensiva, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 9. Department of Respiratory Medicine, Geneva University Hospital, Geneva, Switzerland. 10. Unidad de terapia Intensiva, Hospital Civil Fray Antonio Alcalde Guadalajara, Jalisco, México. 11. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, China Medical University, Shenyang, China. 12. CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, Tours, France; INSERM, Centre d'étude des pathologies respiratoires, Université de Tours, Tours, France. 13. Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University, Chicago, IL 60612, USA. Electronic address: jie_li@rush.edu.
We read the comments from Qinyuan Li and colleagues on our published systematic review and meta-analysis on awake prone positioning in patients with COVID-19-related acute hypoxaemic respiratory failure. We appreciate their interest in our study, and welcome the opportunity to further explain some of the finer details of our study.Qinyuan Li and colleagues challenge our methods on the basis of the two small cluster randomised controlled trials (RCTs)2, 3 included in our meta-analysis. As shown in figure 2 of our paper, no intubation or death occurred in either group in these two trials. Therefore, they could not contribute any information to the meta-analysis of intubation and mortality. As recommended by the Cochrane Handbook, we performed a sensitivity analysis to establish the robustness of our results after removing these two cluster RCTs (appendix). These findings are supported by the helpful analysis presented by Qinyuan Li and colleagues, given that their adjusted forest plots also show no difference between awake prone positioning and standard care for these three secondary outcomes.We agree with Qinyuan Li and colleagues that unlike individual RCTs, the potential for bias in cluster RCTs might arise from how individual participants were identified and recruited within clusters. In fact, this issue is why we carefully evaluated recruitment bias, baseline imbalance, loss of clusters, incorrect analysis, and comparability with individual RCTs, in accordance with chapter 23 of the Cochrane handbook. We incorporated the identification and recruitment bias from cluster RCTs in allocation concealment, which were classified as unclear.Finally, Qinyuan Li and colleagues argue that blinding was not considered in the Grading of Recommendations Assessment, Development and Evaluation assessment. This statement is incorrect. In fact, we do mention the absence of blinding in the first footnote to supplementary table 5 (appendix p 22). Blinding a behavioural intervention such as awake prone positioning is impossible and is irrelevant for an objective outcome such as death. We assume that the absence of blinding is unlikely to induce a strong bias in assessing the cumulative incidence of intubation, which is, again, an objectively measured outcome. Of note, Qinyuan Li and colleagues claim that no blinding exaggerates the intervention effects by 13%. However, they cite a paper that reported a combination of subjective and objective outcomes, and “evidence was weak for an influence of double-blinding in trials with objectively assessed or all-cause mortality outcomes”, according to that same paper. More precisely, outcomes such as intubation are considered to be “objectively measured but potentially influenced by clinician judgment”, which is associated with a low risk of bias according to Savović and colleagues. Accordingly, we evaluated the risk of bias as being not serious (appendix p 22).In short, we maintain that our conclusions remain accurate, and we appreciate this opportunity to clarify our methods.Competing interests remain the same as in the original Article.
Authors: Jelena Savović; Hayley E Jones; Douglas G Altman; Ross J Harris; Peter Jüni; Julie Pildal; Bodil Als-Nielsen; Ethan M Balk; Christian Gluud; Lise Lotte Gluud; John P A Ioannidis; Kenneth F Schulz; Rebecca Beynon; Nicky J Welton; Lesley Wood; David Moher; Jonathan J Deeks; Jonathan A C Sterne Journal: Ann Intern Med Date: 2012-09-18 Impact factor: 25.391
Authors: Stephanie Parks Taylor; Henry Bundy; William M Smith; Sara Skavroneck; Brice Taylor; Marc A Kowalkowski Journal: Ann Am Thorac Soc Date: 2021-08
Authors: Jie Li; Jian Luo; Ivan Pavlov; Yonatan Perez; Wei Tan; Oriol Roca; Elsa Tavernier; Aileen Kharat; Bairbre McNicholas; Miguel Ibarra-Estrada; David L Vines; Nicholas A Bosch; Garrett Rampon; Steven Q Simpson; Allan J Walkey; Michael Fralick; Amol Verma; Fahad Razak; Tim Harris; John G Laffey; Claude Guerin; Stephan Ehrmann Journal: Lancet Respir Med Date: 2022-03-16 Impact factor: 102.642